CSI Market
Sign In | Register

Mirum Pharmaceuticals Inc (MIRM) Annual Balance Sheets

Annual · GAAP · USD millions
Access MIRM quarterly Balance Sheets →
This balance sheet overview for Mirum Pharmaceuticals Inc spans from Dec 31 2021 to Dec 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent296.68
Combined Cash+Investments Total (filer-reported)391.40
Short-term Investments, Total86.64
Cash & Short-term Investments382.00
Accounts receivable123.33
Inventories24.89
Other Current Assets0.00
Prepaid Expense And Other Assets Current18.14
Total Current Assets549.68
Equipment/Property/Plant Net1.86
Intangible Assets260.92
Long-term investments8.11
Other Assets, Noncurrent30.35
Restricted Cash Equivalents-
Operating Lease Right Of Use Asset8.74
Total Assets842.81
Liabilities
Accounts Payable, Current AC9.61
Accrued Liabilities, Current AC0.00
Derivative Liability, Current DE0.00
Other Liabilities, Current196.19
Total Current Liabilities205.80
Convertible Notes Payable, Noncurrent LO309.80
Total Long-term Debt309.80
Other liabilities, Noncurrent12.53
Accrued Liabilities And Other Liabilities Current196.19
Operating Lease Liability Noncurrent7.52
Total Liabilities528.12
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock981.88
Retained Earnings / Accumulated Deficit-667.54
Other Equity0.35
Common Stockholder's Equity314.69
Total Stockholder's Equity314.69
Liabilities & Stockholder's Equity842.81
4 historic quarters locked

Sign in to unlock the full Mirum Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Mirum Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: mirm-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001759425-26-000013

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License